| Literature DB >> 29348774 |
Hammad Ismail1, Ammara Rasheed2, Ihsan-Ul Haq3, Laila Jafri4, Nazif Ullah5, Erum Dilshad6, Moniba Sajid2, Bushra Mirza2.
Abstract
Five medicinal plants of Pakistan were investigated for their antinociceptive, anti-inflammatory, antidepressant, and anticoagulant potential. Antinociceptive activity was estimated by hot plate and writhing assay. In hot plate assay, Quercus dilatata (52.2%) and Hedera nepalensis (59.1%) showed moderate while Withania coagulans (65.3%) displayed a significant reduction in pain. On the other hand, in writhing assay, Quercus dilatata (49.6%), Hedera nepalensis (52.7%), and Withania coagulans (62.0%) showed comparative less activity. In anti-inflammatory assays crude extracts showed significant edema inhibition in a dose dependent manner. In carrageenan assay, the highest activity was observed for Withania coagulans (70.0%) followed by Quercus dilatata (66.7%) and Hedera nepalensis (63.3%). Similar behavior was observed in histamine assay with percentage inhibitions of 74.3%, 60.4%, and 63.5%, respectively. Antidepressant activity was estimated by forced swim test and the most potent activity was revealed by Withania coagulans with immobility time 2.2s (95.9%) followed by Hedera nepalensis with immobility time 25.3s (53.4%). Moreover, the crude extracts of Fagonia cretica (74.6%), Hedera nepalensis (73.8%), and Phytolacca latbenia (67.3%) showed good anticoagulant activity with coagulation times 86.9s, 84.3s, and 67.5s, respectively. Collectively, the results demonstrate that these five plants have rich medicinal constituents which can be further explored.Entities:
Year: 2017 PMID: 29348774 PMCID: PMC5733623 DOI: 10.1155/2017/7849501
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Latency time in hot plate assay.
| Treatment | Dose | ¥Latency time (sec) | |||
|---|---|---|---|---|---|
| 0 min | 30 min | 60 min | 120 min | ||
| Saline | 10 ml/Kg | 4.7 ± 0.06 | 4.7 ± 0.1 | 4.6 ± 0.15 | 4.8 ± 0.06 |
|
| |||||
| Morphine | 10 mg/Kg | 8.7 ± 0.10 | 12.4 ± 0.10 | 15.3 ± 0.20 | 14.3 ± 0.10 |
| 5 mg/Kg | 8.6 ± 0.10 | 11.4 ± 0.15 | 13.6 ± 0.25 | 12.7 ± 0.20 | |
| 2.5 mg/Kg | 8.3 ± 0.20 | 10.6 ± 0.15 | 12.6 ± 0.15 | 12.2 ± 0.21 | |
|
| |||||
|
| 200 mg/Kg | 7.3 ± 0.20 | 8.6 ± 0.31 | 10.5 ± 0.20 | 10.0 ± 0.21 |
| 100 mg/Kg | 6.9 ± 0.15 | 8.3 ± 0.30 | 9.7 ± 0.15 | 9.2 ± 0.25 | |
| 50 mg/Kg | 5.5 ± 0.15 | 6.1 ± 0.10 | 6.9 ± 0.15 | 6.4 ± 0.23 | |
|
| |||||
|
| 200 mg/Kg | 17.2 ± 0.15 | 20.7 ± 0.21 | 23.7 ± 0.20 | 23.0 ± 0.15 |
| 100 mg/Kg | 16.0 ± 0.20 | 18.3 ± 0.21 | 20.1 ± 0.15 | 19.6 ± 0.26 | |
| 50 mg/Kg | 14.4 ± 0.21 | 15.2 ± 0.21 | 16.1 ± 0.15 | 16.7 ± 0.15 | |
|
| |||||
|
| 200 mg/Kg | 16.4 ± 0.12 | 20.3 ± 0.21 | 25.3 ± 0.30 | 24.3 ± 0.17 |
| 100 mg/Kg | 15.5 ± 0.15 | 18.5 ± 0.10 | 22.5 ± 0.32 | 21.8 ± 0.44 | |
| 50 mg/Kg | 10.6 ± 0.17 | 11.1 ± 0.26 | 13.5 ± 0.26 | 14.0 ± 0.15 | |
|
| |||||
|
| 200 mg/Kg | 15.4 ± 0.10 | 17.0 ± 0.21 | 20.1 ± 0.35 | 19.6 ± 0.15 |
| 100 mg/Kg | 14.8 ± 0.15 | 15.2 ± 0.25 | 17.4 ± 0.38 | 16.7 ± 0.38 | |
| 50 mg/Kg | 11.8 ± 0.15 | 12.0 ± 0.15 | 12.4 ± 0.15 | 12.1 ± 0.31 | |
|
| |||||
|
| 200 mg/Kg | 7.3 ± 0.25 | 9.6 ± 0.38 | 11.7 ± 0.21 | 10.9 ± 0.46 |
| 100 mg/Kg | 7.0 ± 0.21 | 8.3 ± 0.15 | 10.3 ± 0.21 | 9.8 ± 0.26 | |
| 50 mg/Kg | 4.2 ± 0.10 | 4.6 ± 0.10 | 5.5 ± 0.12 | 5.2 ± 0.10 | |
Mean values with SD expressed in p < 0.05, p < 0.01 statistical significance compared with saline group.
Figure 1Percentage inhibition in hot plate assay at different time intervals. Values expressed in mean ± SD with statistical significance p < 0.05, p < 0.01 where “ns” represents nonsignificance.
Comparison of five plant activities in different assays.
| Crude plant extract | Percentage Activity | |||||
|---|---|---|---|---|---|---|
| Analgesic assays¥ | Antidepressant assay§ | Anticoagulant assay§ | Anti-inflammatory assays¥ | |||
| Hot plate | Writhing | Carrageenan | Histamine | |||
|
| 52.2% | 49.6% | 0% | 30.1% | 66.7% | 60.4% |
|
| 43.4% | 39.3% | 35.4% | 74.6% | 53.3% | 52.4% |
|
| 59.1% | 52.7% | 53.4% | 73.8% | 63.3% | 63.5% |
|
| 36.0% | 25.8% | 0% | 67.3% | 53.3% | 47.4% |
|
| 65.3% | 62.0% | 95.9% | 29.8% | 70.0% | 74.3% |
Expressed as mean of highest activity. Calculated from negative control group.
Figure 2Percentage inhibition in writhing assay. Values expressed in mean ± SD with statistical significance p < 0.05, p < 0.01.
Edema volume of rat's paw in carrageenan assay.
| Treatment | Dose | ¥Absolute edema volume (ml) | |||
|---|---|---|---|---|---|
| 1 h | 2 h | 3 h | 4 h | ||
| Saline | 10 ml/Kg | 0.24 ± 0.02 | 0.27 ± 0.03 | 0.30 ± 0.01 | 0.27 ± 0.02 |
|
| |||||
| Diclofenac potassium | 10 mg/Kg | 0.14 ± 0.005 | 0.10 ± 0.003 | 0.08 ± 0.02 | 0.07 ± 0.01 |
| 5 mg/Kg | 0.15 ± 0.06 | 0.14 ± 0.002 | 0.09 ± 0.05 | 0.08 ± 0.02 | |
| 2.5 mg/Kg | 0.16 ± 0.04 | 0.16 ± 0.05 | 0.15 ± 0.01 | 0.14 ± 0.03 | |
|
| |||||
|
| 200 mg/Kg | 0.14 ± 0.03 | 0.14 ± 0.04 | 0.10 ± 0.02 | 0.10 ± 0.02 |
| 100 mg/Kg | 0.18 ± 0.02 | 0.17 ± 0.03 | 0.15 ± 0.005 | 0.14 ± 0.05 | |
| 50 mg/Kg | 0.22 ± 0.05 | 0.23 ± 0.02 | 0.20 ± 0.06 | 0.19 ± 0.01 | |
|
| |||||
|
| 200 mg/Kg | 0.16 ± 0.05 | 0.16 ± 0.06 | 0.14 ± 0.02 | 0.14 ± 0.005 |
| 100 mg/Kg | 0.20 ± 0.06 | 0.19 ± 0.02 | 0.20 ± 0.04 | 0.19 ± 0.05 | |
| 50 mg/Kg | 0.21 ± 0.04 | 0.22 ± 0.02 | 0.21 ± 0.05 | 0.22 ± 0.03 | |
|
| |||||
|
| 200 mg/Kg | 0.12 ± 0.01 | 0.13 ± 0.01 | 0.11 ± 0.05 | 0.12 ± 0.02 |
| 100 mg/Kg | 0.17 ± 0.02 | 0.16 ± 0.03 | 0.18 ± 0.06 | 0.18 ± 0.01 | |
| 50 mg/Kg | 0.19 ± 0.02 | 0.20 ± 0.04 | 0.21 ± 0.03 | 0.20 ± 0.03 | |
|
| |||||
|
| 200 mg/Kg | 0.16 ± 0.02 | 0.16 ± 0.05 | 0.14 ± 0.02 | 0.13 ± 0.05 |
| 100 mg/Kg | 0.16 ± 0.02 | 0.18 ± 0.04 | 0.17 ± 0.05 | 0.16 ± 0.04 | |
| 50 mg/Kg | 0.20 ± 0.03 | 0.19 ± 0.01 | 0.20 ± 0.04 | 0.18 ± 0.03 | |
|
| |||||
|
| 200 mg/Kg | 0.14 ± 0.01 | 0.13 ± 0.01 | 0.09 ± 0.04 | 0.09 ± 0.05 |
| 100 mg/Kg | 0.18 ± 0.06 | 0.16 ± 0.05 | 0.13 ± 0.03 | 0.09 ± 0.04 | |
| 50 mg/Kg | 0.20 ± 0.05 | 0.19 ± 0.06 | 0.17 ± 0.04 | 0.16 ± 0.02 | |
Calculated from respective hour paw volume – 0 hour paw volume. Expressed as mean ± SD with p < 0.05, p < 0.01, and p < 0.001 statistical significance compared with saline group.
Figure 3Percentage inhibition in carrageenan assay at different time intervals. Values expressed in mean ± SD with statistical significance p < 0.05, p < 0.01, and p < 0.001 where “ns” represents nonsignificance.
Figure 4Percentage inhibition in histamine assay at different time intervals. Values expressed in mean ± SD with statistical significance p < 0.05, p < 0.01 where “ns” represents nonsignificance.
Figure 5Results of antidepressant assay. Values expressed in mean ± SD with statistical significance p < 0.05, p < 0.01, and p < 0.001 where “ns” represents nonsignificance.
Figure 6Results of anticoagulant assay. Values expressed in mean ± SD with statistical significance p < 0.05, p < 0.01, and p < 0.001.